Drug Shortage Report for M-BETAHISTINE
| Report ID | 182169 |
| Drug Identification Number | 02519690 |
| Brand name | M-BETAHISTINE |
| Common or Proper name | M-Betahistine |
| Company Name | MANTRA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAHISTINE HYDROCHLORIDE |
| Strength(s) | 16MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N07CA |
| ATC description | ANTIVERTIGO PREPARATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-16 |
| Estimated end date | 2023-03-20 |
| Actual end date | 2023-03-03 |
| Shortage status | Resolved |
| Updated date | 2023-03-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-03-06 | French | Compare |
| v4 | 2023-03-06 | English | Compare |
| v3 | 2023-02-20 | French | Compare |
| v2 | 2023-02-20 | English | Compare |
| v1 | 2023-01-20 | English | Compare |
Showing 1 to 5 of 5